4-butyrolactone has been researched along with Colorectal Neoplasms in 8 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 1 (12.50) | 18.2507 |
2000's | 3 (37.50) | 29.6817 |
2010's | 3 (37.50) | 24.3611 |
2020's | 1 (12.50) | 2.80 |
Authors | Studies |
---|---|
An, T; Cai, B; Chen, L; Duan, A; Ju, X; Kong, L; Li, X; Li, Y; Yang, Q | 1 |
Chang, SH; Kang, CH; Kang, D; Kim, CS; Ko, KP; Koriyama, C; Lim, YK; Ngoan, LT; Park, SK; Shin, HR; Tokudome, S; Yeo, Y; Yoo, KY; Yoon, JH | 1 |
Frederiksen, K; Holm, M; Knudsen, KEB; Kyrø, C; Nørskov, NP; Olsen, A; Overvad, K; Tjønneland, A | 1 |
Adebayo, BO; Chang, TC; Deng, L; Hsiao, M; Huang, CC; Lee, WH; Lin, YC; Rao, YK; Tzeng, YM; Wang, LS; Wu, AT; Wu, CH; Yeh, CT | 1 |
Arts, IC; Hollman, PC; Kampman, E; Kuijsten, A; van't Veer, P | 1 |
Arts, IC; Feskens, EJ; Hollman, PC; Kampman, E; Kuijsten, A; Milder, IE; Van 't Veer, P | 1 |
Adlercreutz, H | 1 |
Lu, Y; Takebe, H; Yagi, T; Yamagishi, N | 1 |
1 review(s) available for 4-butyrolactone and Colorectal Neoplasms
Article | Year |
---|---|
Lignans and human health.
Topics: 4-Butyrolactone; Animals; Cardiovascular Diseases; Colorectal Neoplasms; Dietary Fiber; Edible Grain; Endometrial Neoplasms; Feeding Behavior; Female; Health Status; Humans; Isoflavones; Lignans; Male; Phytoestrogens; Plants, Edible; Prostatic Neoplasms; Seeds; Vegetables | 2007 |
7 other study(ies) available for 4-butyrolactone and Colorectal Neoplasms
Article | Year |
---|---|
Parthenolide inhibits ubiquitin-specific peptidase 7 (USP7), Wnt signaling, and colorectal cancer cell growth.
Topics: 4-Butyrolactone; Apoptosis; beta Catenin; Cell Cycle; Cell Line, Tumor; Cell Proliferation; Colorectal Neoplasms; Down-Regulation; Enzyme Inhibitors; Gene Expression Regulation, Neoplastic; HEK293 Cells; Humans; Proteolysis; Sesquiterpenes; Ubiquitin-Specific Peptidase 7; Ubiquitination; Wnt Signaling Pathway | 2020 |
Plasma phytoestrogens concentration and risk of colorectal cancer in two different Asian populations.
Topics: 4-Butyrolactone; Adult; Aged; Asian People; Case-Control Studies; Colorectal Neoplasms; Female; Genistein; Humans; Isoflavones; Lignans; Male; Middle Aged; Phytoestrogens; Republic of Korea; Risk Factors; Vietnam | 2018 |
Prediagnosis plasma concentrations of enterolactone and survival after colorectal cancer: the Danish Diet, Cancer and Health cohort.
Topics: 4-Butyrolactone; Aged; Cohort Studies; Colorectal Neoplasms; Denmark; Diet; Female; Humans; Incidence; Lignans; Male; Middle Aged; Survival Analysis | 2019 |
4-Acetylantroquinonol B inhibits colorectal cancer tumorigenesis and suppresses cancer stem-like phenotype.
Topics: 4-Butyrolactone; Animals; Antineoplastic Agents, Phytogenic; Antineoplastic Combined Chemotherapy Protocols; Cell Proliferation; Colorectal Neoplasms; Cyclohexanones; Dose-Response Relationship, Drug; Drug Resistance, Neoplasm; Fluorouracil; Gene Expression Regulation, Neoplastic; HCT116 Cells; HT29 Cells; Humans; Leucovorin; Mice, Inbred NOD; Mice, SCID; Neoplastic Stem Cells; Organoplatinum Compounds; Phenotype; Signal Transduction; Spheroids, Cellular; Time Factors; Tumor Burden; Xenograft Model Antitumor Assays | 2015 |
Plasma enterolignans are associated with lower colorectal adenoma risk.
Topics: 4-Butyrolactone; Adenoma; Case-Control Studies; Chromatography, Liquid; Colorectal Neoplasms; Diet; Female; Humans; Incidence; Lignans; Middle Aged; Netherlands; Odds Ratio; Retrospective Studies; Spectrometry, Mass, Electrospray Ionization; Surveys and Questionnaires | 2006 |
Relation between plasma enterodiol and enterolactone and dietary intake of lignans in a Dutch endoscopy-based population.
Topics: 4-Butyrolactone; Adenomatous Polyps; Adult; Aged; Case-Control Studies; Colonoscopy; Colorectal Neoplasms; Diet; Female; Humans; Lignans; Male; Middle Aged; Phytoestrogens | 2007 |
Mutated p21(WAF1/CIP1/SDI1) lacking CDK-inhibitory activity fails to prevent apoptosis in human colorectal carcinoma cells.
Topics: 4-Butyrolactone; Apoptosis; CDC2-CDC28 Kinases; Cell Survival; Colorectal Neoplasms; Cyclin-Dependent Kinase 2; Cyclin-Dependent Kinase Inhibitor p21; Cyclin-Dependent Kinases; Cyclins; Doxorubicin; Enzyme Inhibitors; Humans; Isopropyl Thiogalactoside; Mimosine; Mutation; Proliferating Cell Nuclear Antigen; Protein Kinase Inhibitors; Protein Serine-Threonine Kinases; Tumor Cells, Cultured; X-Rays | 1998 |